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In nature, prokaryotes can form supramolecular, self-assembling protein compartments, known as bacterial
microcompartments (BMCs)1 and nanocompartments which are associated with various metabolic processes.
The modular nature and relative ease of recombinant production2 of such systems has sparked interest into redesigning these structures with new functionalities. The design of robust platforms with different applications
requires understanding and control over particle formation, protein display/encapsulation and stability of
engineered variants. Using synthetic biology tools, we gain insights into those properties and the suitability of
diverse nano- and microcompartment systems for versatile applications.
Here we will demonstrate two examples of protein nanoparticle engineering: (1) the design of a modular drug
delivery platform and (2) a vaccine platform for the oriented display of antigens. The modular drug delivery
platform was generated by fusing Designed Ankyrin Repeat Proteins (DARPins), a monoclonal antibody mimic
for the specific binding to Human Epidermal growth factor Receptor 2 (HER2), to the capsid protein of the
Thermotoga maritima encapsulin. The capsid was loaded with a photosensitive protein mini-Singlet Oxygen
Generator (miniSOG). The entire drug delivery particle was generated by co-expression of two genes from a
single plasmid and a simple purification step. The purified encapsulin-DARPin_miniSOG nanocompartment was
shown to bind specifically to HER2-positive breast cancer cells triggering apoptosis after activation of miniSOG
and release of reactive oxygen species, indicating that the system is functional3. The second application that we
will present is a modular vaccine platform for the oriented display of antigens. Here, antigens of interest are
displayed on the surface of the T. maritima encapsulin nanoparticle using non-covalent interactions with highaffinity picomolar-scale dissociation constants. The platform is tuneable and has the potential to be employed to
generate mosaic vaccines composed of various antigens. Our work demonstrates proof of concept for the
suitability of encapsulin systems as modular platforms for the bio-manufacture of future therapeutics.
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